Clinical Characteristics, Associated Factors, and Predicting COVID-19 Mortality Risk: A Retrospective Study in Wuhan, China
- 1 August 2020
- journal article
- research article
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 59 (2) , 168-175
Abstract
No abstract availableKeywords
Funding Information
- Huazhong University of Science and Technology
This publication has 33 references indexed in Scilit:
- Nonlaboratory-Based Risk Assessment Algorithm for Undiagnosed Type 2 Diabetes Developed on a Nation-Wide Diabetes SurveyDiabetes Care, 2013
- Plasma procalcitonin is associated with all-cause and cancer mortality in apparently healthy men: a prospective population-based studyBMC Medicine, 2013
- Exogenous procalcitonin evokes a pro-inflammatory cytokine responseInflammation Research, 2010
- Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human PrimatesPLOS Pathogens, 2010
- Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic targetBritish Journal of Pharmacology, 2010
- Studies reporting ROC curves of diagnostic and prediction data can be incorporated into meta-analyses using corresponding odds ratiosJournal of Clinical Epidemiology, 2007
- Procalcitonin increase in early identification of critically ill patients at high risk of mortality*Critical Care Medicine, 2006
- Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARSDiabetic Medicine, 2006
- The Immunopathogenesis of Sepsis in Elderly PatientsClinical Infectious Diseases, 2005
- Outcomes and Prognostic Factors in 267 Patients with Severe Acute Respiratory Syndrome in Hong KongAnnals of Internal Medicine, 2003